Any current/future new fundraising through debt or equity?

There is no mention of any current or planned fundraising through debt or equity in the provided transcript. The company discusses ongoing capex of about Rs 150 crores annually, with some projects being commissioned, but no new fundraising related to this is indicated. The focus is on volume growth, innovation, and expanding geographical presence, rather than raising capital. No specific guidance or plans about raising funds via debt or equity were disclosed during the call.

Any current/future capex/capital investment/strategic investment?

Galaxy Surfactants typically targets around Rs 150 crores of capital expenditure annually. In the current year, capex is expected to be around Rs 150 crores as well. Recent capex includes projects currently being commissioned, resulting in some incremental spending this year. Capex is allocated across various segments, including mild surfactants, performance products, and specialty products. The company is also investing strategically to improve capacities and capabilities to leverage growth opportunities. Setting up a new office in Europe is a strategic move to deepen presence and explore gro

Future growth expectations in sales/revenue/volumes?

Volume growth remains a key priority, with Q2 volume growth at 9.8% and H1 at 8.6%, exceeding the 6%-8% guidance band. Confident of achieving the upper range of volume growth guidance going forward. India market expected to maintain double-digit volume growth, driven by increased participation across Tier 1, 2, and 3 customers, and rising HPC per capita consumption. Developed markets (Europe, North America) expected to show volume and specialty growth recovery starting early next year. Africa, Middle East, and Turkey showed strong volume growth, especially Egypt; other markets expected to impr

Future growth expectations in earnings/operating earnings/profits/EPS?

Galaxy Surfactants expects volume growth of 6% to 8% for FY '24, with potential for higher EBITDA and PAT growth than volume. EBITDA per metric ton is forecasted to remain within the band of INR 19,500 to INR 20,500 for the full year. Growth in premium specialties, especially in developed markets like Europe and North America, is seen as critical to improving EBITDA per ton and overall profitability. The company is confident of sustaining strong growth momentum, particularly driven by the India market's double-digit volume growth and improved performance in Africa, Middle East, Turkey, a

Galaxy Surfactants LtdQ2 FY24Chemicals & Petrochemicals

Galaxy Surfactants Ltd Q2 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹2,502P/E: 24.4Market Cap: ₹8.9K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

Volume growth remains a key priority, with Q2 volume growth at 9.8% and H1 at 8.6%, exceeding the 6%-8% guidance band.
Confident of achieving the upper range of volume growth guidance going forward.
India market expected to maintain double-digit volume growth, driven by increased participation across Tier 1, 2, and 3 customers, and rising HPC per capita consumption.
Developed markets (Europe, North America) expected to show volume and specialty growth recovery starting early next year.
Africa, Middle East, and Turkey showed strong volume growth, especially Egypt; other markets expected to improve sequentially.
Developed markets have been volatile, but with positive customer sentiment and easing inflation, a strong comeback in volume growth is expected in 2024.
Growth in specialty chemicals, especially premium specialties, is critical for improving EBITDA per metric ton and overall revenue quality.

Margin guidance

Category 3

Galaxy Surfactants expects volume growth of 6% to 8% for FY '24, with potential for higher EBITDA and PAT growth than volume.
EBITDA per metric ton is forecasted to remain within the band of INR 19,500 to INR 20,500 for the full year.
Growth in premium specialties, especially in developed markets like Europe and North America, is seen as critical to improving EBITDA per ton and overall profitability.
The company is confident of sustaining strong growth momentum, particularly driven by the India market's double-digit volume growth and improved performance in Africa, Middle East, Turkey, and other developing markets.
Innovation and R&D spend at 1-1.5% of sales, focused on premium specialty chemicals, are expected to support growth.
Management is optimistic about medium to long-term prospects, barring unforeseen macroeconomic or geopolitical challenges.

See what Galaxy Surfactants Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

There is no mention of any current or planned fundraising through debt or equity in the provided transcript.
The company discusses ongoing capex of about Rs 150 crores annually, with some projects being commissioned, but no new fundraising related to this is indicated.
The focus is on volume growth, innovation, and expanding geographical presence, rather than raising capital.
No specific guidance or plans about raising funds via debt or equity were disclosed during the call.

Order book

The transcript provided from the Q2 FY '24 earnings call of Galaxy Surfactants Limited does not explicitly mention specific details regarding the current or expected order book or pending orders. However, the following points related to business momentum and growth can be inferred: - The company has seen robust volume growth of 9.8% in Q2 and 8.6% in H1, exceeding guidance, indicating strong demand. - There is positive momentum across all segments and regions, including India, Africa, Middle East, Turkey, and rest of the world markets. - Supply side capabilities and capacities are well prepared to leverage growth opportunities. - The company continues to focus on specialty chemicals, including premium specialty volumes growing. - While detailed order book numbers are not disclosed, management prioritizes profitable volume growth and is confident about continuing momentum in H2 FY '24. No direct commentary on exact order book or pending orders was provided in the sections shared.

See what Galaxy Surfactants Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

Galaxy Surfactants typically targets around Rs 150 crores of capital expenditure annually.
In the current year, capex is expected to be around Rs 150 crores as well.
Recent capex includes projects currently being commissioned, resulting in some incremental spending this year.
Capex is allocated across various segments, including mild surfactants, performance products, and specialty products.
The company is also investing strategically to improve capacities and capabilities to leverage growth opportunities.
Setting up a new office in Europe is a strategic move to deepen presence and explore growth in the fragmented European market, but no instant revenue impact is expected.
Continued investment in innovation and R&D (about 1% to 1.5% of sales) supports growth in premium specialty chemicals.

Track Galaxy Surfactants Ltd — get its next earnings analysis in your feed

How does Galaxy Surfactants Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

ThisGalaxy Surfactants Ltd

Rev 3Mar 3

See where Galaxy Surfactants Ltd sits in Chemicals & PetrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does Galaxy Surfactants Ltd rank in Chemicals & Petrochemicals?

Compare Galaxy Surfactants Ltd against every Chemicals & Petrochemicals company (Q2 FY24) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

What Galaxy Surfactants Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

Paushak Ltd (Q2 FY27)
Year-on-year increase in quarterly revenue: Rs 3,054 lakhs (approximately 52% growth) . Key results statement takeaways from Paushak Ltd's Q2 FY27 results state
Platinum Industries Ltd (Q2 FY26)
Q2FY26 Revenue from Operations (Consolidated): INR 983.8 Mn, down 1% YoY from INR 996.4 Mn in Q2FY25. Key investor presentation takeaways from Platinum Industri
Neogen Chemicals Ltd (Q2 FY26)
Neogen Chemicals rebuilding plant with potential incremental capex post insurance evaluation, mostly double-digit crores, no large capex planned next 1-2…
Vishnu Chemicals Ltd (Q2 FY26)
Q2FY26 operating revenues: ₹401.1 Cr, a 16.7% year-on-year (YoY) increase from ₹343.8 Cr in Q2FY25. Key investor presentation takeaways from Vishnu Chemicals Lt

Compare:vs Solar Industries vs SRF Ltd vs Linde India Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Galaxy Surfactants Ltd Q2 FY24 Earnings Call Analysis

Revenue guidance

Fundraise plans

Capex plans

How does Galaxy Surfactants Ltd rank in Chemicals & Petrochemicals?

Continue your research

What Galaxy Surfactants Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season